Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary...
Sponsored by ImmunoGen Incorporated
$111.4K Funding
1 People
External
Related Topics
ovarian cancer,
chemotherapy,
clinical trial,
platinum-resistant,
mirvetuximab soravtansine
People
Setsuko Chambers
Principal Investigator (PI)
Obstetrics and Gynecology
﹒Professor